학술논문
Margetuximab Versus Trastuzumab in Patients with Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results from a Randomized Phase 3 Trial
Document Type
Article
Author
Rugo, H.S.; Im, S.-A.; Cardoso, F.; Cortes, J.; Curigliano, G.; Musolino, A.; Pegram, M.D.; Bachelot, T.; Wright, G.S.; Saura, C.; Escrivá-De-Romaní, S.; De Laurentiis, M.; Schwartz, G.N.; Pluard, T.J.; Ricci, F.; Gwin, W.R.; Levy, C.; Brown-Glaberman, U.; Ferrero, J.-M.; De Boer, M.; Kim, S.-B.; Petráková, K.; Yardley, D.A.; Freedman, O.; Jakobsen, E.H.; Gal-Yam, E.N.; Yerushalmi, R.; Fasching, P.A.; Kaufman, P.A.; Ashley, E.J.; Perez-Olle, R.; Hong, S.; Rosales, M.K.; Gradishar, W.J.
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 10 January 2023, 41(2):198-205)
Subject
Language
English
ISSN
15277755
0732183X
0732183X